|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-3-31
|
|
pubmed:abstractText |
Tumor necrosis factor-alpha (TNF-alpha) is a proinflammatory cytokine. Agents that neutralize TNF-alpha are effective in the treatment of disorders such as rheumatoid arthritis, juvenile rheumatoid arthritis (JRA), spondyloarthropathies, and inflammatory bowel disease. TNF-alpha antagonist therapy has been associated with the development of antinuclear antibodies (ANA) and double-stranded DNA (dsDNA) antibodies, as well as the infrequent development of systemic lupus erythematosus (SLE)-like disease. We describe the first case of biopsy-confirmed proliferative lupus nephritis and leukocytoclastic vasculitis in a patient treated with etanercept for JRA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
740-3
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:15801034-Adult,
pubmed-meshheading:15801034-Antirheumatic Agents,
pubmed-meshheading:15801034-Arthritis, Juvenile Rheumatoid,
pubmed-meshheading:15801034-Disease-Free Survival,
pubmed-meshheading:15801034-Female,
pubmed-meshheading:15801034-Humans,
pubmed-meshheading:15801034-Immunocompromised Host,
pubmed-meshheading:15801034-Immunoglobulin G,
pubmed-meshheading:15801034-Lupus Nephritis,
pubmed-meshheading:15801034-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:15801034-Recombinant Fusion Proteins,
pubmed-meshheading:15801034-Vasculitis, Leukocytoclastic, Cutaneous,
pubmed-meshheading:15801034-Withholding Treatment
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept.
|
|
pubmed:affiliation |
Division of Rheumatology, Department of Medicine, New York University School of Medicine/Hospital for Joint Diseases, New York, New York, USA. mora01@med.nyu.edu
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
